VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Capricor Therapeutics, Inc. (CAPR) Total Return Calculator with Dividends Reinvested

Capricor Therapeutics, Inc.

Popular:

The total return for Capricor Therapeutics, Inc. (CAPR) stock is +392.60% over the past 12 months. So far it's up 19.89% this year. The 5-year total return is +878.10%, meaning $10,000 invested in CAPR stock 5 years ago would be worth $97,810 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in CAPR 1 year ago, it would be worth $48,694 today — you'd have gained $38,694.

With Dividends Reinvested$48,694+386.94%

Price Only (No DRIP)$48,694+386.94%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in CAPR

1Y$49,260+$39,260 (+392.6%)392.6% CAGR

3Y$87,026+$77,026 (+770.3%)105.7% CAGR

5Y$97,810+$87,810 (+878.1%)57.8% CAGR

10Y$9,534-$466 (-4.7%)-0.5% CAGR

15Y$956-$9,044 (-90.4%)-14.5% CAGR

20Y$754-$9,246 (-92.5%)-12.1% CAGR

30Y$754-$9,246 (-92.5%)-8.3% CAGR

Capricor Therapeutics, Inc. did not pay dividends during this period. Total return = price return.

Loading CAPR total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+19.89%	—	+19.89%	—	$11,989
1Y	+392.60%	392.60%	+392.60%	—	$49,260
3Y	+770.26%	105.69%	+770.26%	—	$87,026
5Y	+878.10%	57.79%	+878.10%	—	$97,810
10Y	-4.66%	-0.48%	-4.66%	—	$9,534
15Y	-90.44%	-14.49%	-90.44%	—	$956
20Y	-92.46%	-12.12%	-92.46%	—	$754
30Y	-92.46%	-8.25%	-92.46%	—	$754

Risk & Highlights

Best Year+511.11%2007

Worst Year-90.91%2012

Max Drawdown-67.67%2025-06-06 → 2025-11-25 · Recovered 2025-12-03

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-1.34%	-1.34%	—	+0.41%	-1.8pp
2025	+92.91%	+92.91%	—	+16.64%	+76.3pp
2024	+169.53%	+169.53%	—	+24.00%	+145.5pp
2023	+27.01%	+27.01%	—	+24.81%	+2.2pp
2022	+21.38%	+21.38%	—	-19.95%	+41.3pp

CAPR outperformed the S&P 500 by 362.23pp over the past year (+392.60% vs +30.37%).

Loading summary...

CAPR Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
CAPRCapricor Therapeutics, Inc.	$1.6B	+6.2%	+19.9%	+392.6%	—	+770.3%	+878.1%	-4.7%
SRPTSarepta Therapeutics, Inc.	$2.2B	-9.9%	-2.4%	-43.4%	—	-83.6%	-72.1%	+18.0%
CRSPCRISPR Therapeutics AG	$5.1B	+5.5%	-2.5%	+53.1%	—	-6.3%	-51.3%	+272.0%
EXELExelixis, Inc.	$11.7B	+5.0%	+6.0%	+25.5%	—	+142.8%	+84.0%	+833.5%
FOLDAmicus Therapeutics, Inc.	$4.5B	+0.1%	+1.5%	+137.9%	—	+19.0%	+48.6%	+119.2%
RAREUltragenyx Pharmaceutical Inc.	$2.6B	+12.9%	+10.7%	-21.8%	—	-44.5%	-77.2%	-59.4%
EDITEditas Medicine, Inc.	$297M	+10.6%	+47.8%	+127.8%	—	-68.5%	-91.1%	-90.0%
NTLAIntellia Therapeutics, Inc.	$1.6B	+1.2%	+48.9%	+88.1%	—	-68.3%	-79.8%	-42.9%
BEAMBeam Therapeutics Inc.	$3.2B	+28.5%	+16.0%	+93.9%	—	-5.6%	-55.6%	+67.8%
SGMOSangamo Therapeutics, Inc.	$22M	-60.5%	-77.0%	-84.4%	—	-92.0%	-99.0%	-98.4%
RCKTRocket Pharmaceuticals, Inc.	$398M	+5.5%	+6.1%	-45.2%	—	-82.8%	-91.6%	-91.3%

Compare:CAPR vs SRPT CAPR vs CRSP CAPR vs EXEL CAPR vs SRPT vs CRSP

About CAPR Dividend Returns

Capricor Therapeutics, Inc. (CAPR) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of CAPR over the past year?

Capricor Therapeutics, Inc. (CAPR) delivered a return of 392.60% over the past year. Since CAPR does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in CAPR be worth today?

A $10,000 investment in Capricor Therapeutics, Inc. one year ago would be worth $49,260 today, representing a gain of $39,260.

Q3Does CAPR pay dividends?

Capricor Therapeutics, Inc. (CAPR) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For CAPR, the total return equals the price-only return.

Q4Did CAPR beat the S&P 500?

Yes, Capricor Therapeutics, Inc. (CAPR) outperformed the S&P 500 by 362.23 percentage points over the past year. CAPR delivered a total return of 392.60%, compared to the S&P 500's 30.37%. This 362.23pp alpha means investors in CAPR earned more than a passive S&P 500 index fund.

Q5What is CAPR's worst drawdown?

Capricor Therapeutics, Inc. (CAPR) experienced a maximum drawdown of -67.67% over the past year, declining from its peak on 2025-06-06 to its trough on 2025-11-25. The stock recovered to its prior peak by 2025-12-03. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is CAPR's long-term total return over 10, 20, or 30 years?

Here are Capricor Therapeutics, Inc. (CAPR)'s long-term returns with dividends reinvested. Over 10 years, the total return is -4.7% (-0.5% CAGR) — $10,000 would have grown to $9,534. Over 20 years: -92.5% total return (-12.1% CAGR) — $10,000 → $754. Over 30 years: -92.5% total return (-8.3% CAGR) — $10,000 → $754. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was CAPR's best and worst year?

Capricor Therapeutics, Inc.'s best calendar year was 2007 with a total return of 511.1%. Its worst year was 2012 with a total return of -90.9%. This range shows the volatility investors should expect — the difference between the best and worst year is 602.0 percentage points.